Plain-English translation of NCT04741711 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Heart Failure research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether using ultrasound scans of the lungs and a blood vessel called the inferior vena cava can help doctors make better decisions about heart failure treatment. Half of the participants will receive usual heart failure care, while the other half will have their treatment adjusted based on what ultrasound imaging shows about fluid buildup in their lungs and body. The goal is to see if this ultrasound-guided approach prevents hospitalizations and keeps people healthier.
Doctors know that heart failure patients sometimes have fluid buildup that isn't obvious on physical exam alone. This trial is testing whether using ultrasound to detect early or hidden fluid problems helps doctors adjust medications before patients get so sick they need to go to the hospital.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to either receive usual heart failure care or to have your treatment guided by ultrasound results. If you are in the ultrasound group, you will have lung and blood vessel ultrasound scans performed during visits, and your medications may be adjusted based on what the ultrasound shows. Both groups will be followed for at least 30 days, with visits to assess how you are doing and whether you have been hospitalized. Blood tests to measure heart failure markers will also be done at baseline and at your follow-up visit.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
France